The diagnostic accuracy of 12-point core biopsy of a tumor bed compared to the study of surgically obtained breast tissue in patients with locally advanced triple-negative or HER2-positive breast cancer after neoadjuvant systemic and targeted therapy.

Petr Krivorotko,Sergey Yerechshenko,G.A. Dashyan,Elena Zhiltsova,Alexander Bessonov,Tengiz Tabagua,K. Zernov,Alexander Komyahov,Kirill Nikolaev,L. Gigolaeva,A. Emelyanov,Vladimir Semiglazov,Vladislav Semiglazov,Tatiana Semiglazova

The diagnostic accuracy of 12-point core biopsy of a tumor bed compared to the study of surgically obtained breast tissue in patients with locally advanced triple-negative or HER2-positive breast cancer after neoadjuvant systemic and targeted therapy.

2019

Petr Krivorotko
Sergey Yerechshenko
G.A. Dashyan
Elena Zhiltsova
Alexander Bessonov
Tengiz Tabagua
K. Zernov
Alexander Komyahov
Kirill Nikolaev
L. Gigolaeva
A. Emelyanov
Vladimir Semiglazov
Vladislav Semiglazov
Tatiana Semiglazova

e12097Background: Innovative advances in neoadjuvant systemic and targeted breast cancer therapy implicate surgical treatment in specific patient groups can be avoided. The core biopsy of the tumor...

Keywords:

Targeted therapy
Breast cancer
Biopsy
Oncology
Pathology
HER2 Positive Breast Cancer
Medicine
Internal medicine
locally advanced
core biopsy
in patient
diagnostic accuracy
triple negative
Radiology
breast tissue

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations